As a business model, pharma companies have long included DOJ investigations, fines, lawsuits, judgements and settlements into their cost/benefit analysis.

Now, in an attempt to stem the tide of Pharma corruption and scofflaws officials are hitting them where their heart is--THEIR WALLETS.

Current and future DOJ & HHS investigations resulting in fines and judgements will include PATENT REVOCATION as a part of their "settlements".